Formononetin

Formononetin is an isoflavonoid compound found in red clover that functions as a selective estrogen receptor modulator (SERM). It demonstrates anti-cancer activity by inhibiting the FGFR2/Akt signaling pathway and suppressing angiogenesis through FGF2 pathway modulation.

Origin & History

Formononetin is an isoflavone phytoestrogen naturally occurring in Astragalus mongholicus Bunge and Astragalus membranaceus, traditional Chinese medicinal herbs. It is typically isolated from these plants as a bioactive constituent, though specific extraction methods are not detailed in current research.

Historical & Cultural Context

Formononetin is a main active compound from Astragalus species, which have been used in Traditional Chinese Medicine for centuries to tonify qi and support vitality. While the herbs have extensive traditional use, specific historical applications of isolated formononetin are not documented.

Health Benefits

• Anti-cancer effects: Inhibited breast tumor growth in xenograft models through FGFR2/Akt pathway suppression (PMID: 26575424, animal studies only)
• Anti-angiogenic properties: Reduced FGF2-induced blood vessel formation in preclinical models (PMID: 26575424, preliminary evidence)
• Colon cancer prevention: Activated autophagy/apoptosis and regulated lipid metabolism in colitis-associated cancer mouse models (PMID: 40318528, animal data only)
• Anti-inflammatory action: Inhibited NF-κB/MAPK pathways in cancer models (preliminary evidence from cell studies)
• Potential menopausal support: Clinical trials noted but no specific data available (evidence quality unclear)

How It Works

Formononetin acts as a selective estrogen receptor modulator, binding to both ERα and ERβ receptors with varying affinities. It inhibits cancer cell proliferation by suppressing the FGFR2/Akt signaling pathway, which controls cell survival and growth. Additionally, it demonstrates anti-angiogenic effects by interfering with FGF2-induced blood vessel formation, potentially limiting tumor vascularization.

Scientific Research

Current evidence for formononetin is limited to preclinical studies, with no human clinical trials, RCTs, or meta-analyses identified in available research. Key studies include anti-angiogenic effects in rat aortic rings and mouse xenografts (PMID: 26575424) and colon cancer inhibition in mouse models (PMID: 40318528).

Clinical Summary

Current evidence for formononetin comes primarily from preclinical animal studies and in vitro research. Xenograft studies in mice showed significant inhibition of breast tumor growth through FGFR2/Akt pathway suppression. Anti-angiogenic properties have been demonstrated in laboratory models, showing reduced FGF2-induced blood vessel formation. However, human clinical trials are lacking, and the evidence remains preliminary and limited to animal and cellular studies.

Nutritional Profile

Formononetin is a pure isolated phytochemical compound (isoflavone class), not a whole food ingredient, and therefore has no conventional macronutrient or micronutrient profile. Key chemical characteristics: Molecular formula C16H12O4, molecular weight 268.27 g/mol. It is a O-methylated isoflavone (4'-methoxyisoflavone) naturally occurring in red clover (Trifolium pratense), astragalus (Astragalus membranaceus), and licorice root (Glycyrrhiza uralensis), typically present at concentrations of 0.1–1.5 mg/g dry weight in source plants. As a bioactive compound, it exhibits phytoestrogenic activity with binding affinity to estrogen receptors (ERα and ERβ), estimated at approximately 0.001–0.01% relative binding affinity compared to 17β-estradiol. Bioavailability: Orally administered formononetin undergoes hepatic and intestinal metabolism to its active demethylated metabolite equol (via daidzein intermediate) through gut microbiota-dependent pathways; oral bioavailability is estimated at 20–40% depending on gut microbiome composition and individual metabolizer status. Lipophilicity (logP ≈ 2.6) limits aqueous solubility (~0.03 mg/mL in water), which constrains absorption; formulation in lipid-based delivery systems or nanoparticles has been shown to improve bioavailability by 2–4 fold in preclinical studies. No meaningful fiber, protein, fat, vitamin, or mineral content is applicable as this is a single isolated compound.

Preparation & Dosage

No clinically studied human dosages are available. Animal studies used intraperitoneal doses of 10-20 mg/kg/day in mouse models over 2-5 weeks. Human dosing has not been established. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Other isoflavones, Astragalus extract, EGCG, Curcumin, Quercetin

Safety & Interactions

Safety data for formononetin supplementation in humans is limited due to lack of clinical trials. As an estrogenic compound, it may interact with hormone-sensitive conditions and hormone replacement therapies. Potential interactions with blood thinning medications are possible due to isoflavonoid effects on coagulation. Pregnant and breastfeeding women should avoid formononetin supplements due to unknown effects on fetal development and hormone-sensitive tissues.